BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Lovastatin
,
rs2230926
,
FABP1
,
G-protein-coupled receptor binding
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cell-surface receptors
Summary
General Info
Curated Studies
Most Correlated Studies
Lymphoblastoid cells infected with LMP2A mutant Epstein Barr virus
Melanocytes with inducible oncogenic receptor Xmrk stimulated with EGF
L1000 CMAP - Embryonic kidney HEK293T cells treated with ligand perturbagens
Human mammary epithelial cells (HMECs) cultured with serum from GHR-deficient or normal subjects
Aortic valve interstitial cells treated with gamma-secretase/Notch signaling inhibitor
Explore Curated Studies Results
Literature
Most Relevant Literature
CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells.
Triggering Receptor Expressed on Myeloid Cells-1 Agonist Regulates Intestinal Inflammation via Cd177…
The CD177 c.1291A Allele Leads to a Loss of Membrane Expression and Mimics a CD177-Null Phenotype.
CD177 is a novel IgG Fc receptor and CD177 genetic variants affect IgG-mediated function.
Diagnostic, prognostic, and immunological roles of CD177 in cervical cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic A…
Ocular Surface Microbiome in Dry Eye Patients
Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T C…
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymp…
Dependence Receptors and Leukemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ